
|Articles|January 31, 2022
What's new on Contemporary Pediatrics: January 31 to February 4
A look at what to expect from Contemporary Pediatrics this week
Advertisement
Conventional wisdom says that placebos only work when patients are unaware that they are receiving one, but research in adults shows that isn't always true. An investigation examines whether children with certain gut disorders can be helped with open-label placebos.
Unintentional drug overdoses continue to rise, but most studies of the impact on mortality have focused on adults. Some new research provides insight into how much is lost when teenagers and young adults die from drug overdoses.
Plus, a look at how depression impacts the quality of life for children who have celiac disease.
Advertisement
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
New sunscreen ingredient clears FDA for the first time since the 1990s
2
FDA grants GEn-1123 rare disease designations for Duchenne muscular dystrophy
3
FDA accepts vedolizumab sBLA for pediatric ulcerative colitis and Crohn's disease
4
FDA approves lebrikizumab every-8-week maintenance dosing for moderate-to-severe atopic dermatitis
5


